Open Nav

Squarex, LLC

To find partners or investors.

  • Date:Thursday, October 18
  • Time:10:15 AM - 10:30 AM
  • Room:Olympic
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:We are developing a drug to prevent herpes labialis outbreaks (cold sores) for 6 months with a single topical application. It has proven effective in two separate clinical trials. There are no approved drugs for this indication, and tens of millions of patients.
  • Company
  • Company HQ City:Saint Paul
  • Company HQ Country:United States
  • Company HQ State:Minnesota                  
  • Market Cap:55115
  • Main Therapeutic Focus:Infectious Diseases
  • Lead Product in Development :SQX
  • Development Phase of Primary Product:Phase II
  • Total Amount Raised to Date, In All Rounds:$4.75 million